Professor Ngs research contributions to AOD-9604 development include: Synthesis and characterization of the modified C-terminal growth hormone fragment with enhanced stability Design of the tyrosine N-terminal modification to improve peptide stability and half-life Preclinical studies demonstrating lipolytic effects in obese animal models Advancement of the peptide through multiple phases of clinical development Investigation of mechanisms underlying beta-3-adrenergic receptor modulation His work established the foundation for understanding peptide-based approaches to metabolic regulation, though clinical translation ultimately proved unsuccessful
Adult Recognition and Late Diagnosis Increasingly, adults are recognizing their own neurodivergence, often triggered by their childrens diagnoses, changes in life circumstances, or increased awareness through social media and advocacy efforts
Learn More Research review and sources Primary references and supporting sources Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction Recent preclinical 5A1MQ paper describing obesity, glucose, and liver endpoints
GHK-Cu: Collagen Remodeling and Tissue Quality GHK-Cu is a naturally occurring copper-binding peptide associated with collagen and tissue remodeling pathways
Back to Shop BPC-157 is a peptide supplied for commercial sourcing, research applications, and formulation development
Content Source: American Migraine Foundation National Library of Medicine
